RhumbLine Advisers’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.8M | Buy |
94,579
+1,283
| +1% | +$28.4K | ﹤0.01% | 1913 |
|
|
2025
Q4 | $2.26M | Buy |
93,296
+2,311
| +3% | +$60.5K | ﹤0.01% | 1813 |
|
|
2025
Q3 | $2.32M | Sell |
90,985
-1,923
| -2% | -$45.6K | ﹤0.01% | 1831 |
|
|
2025
Q2 | $2M | Buy |
92,908
+9,681
| +12% | +$218K | ﹤0.01% | 1888 |
|
|
2025
Q1 | $1.9M | Buy |
83,227
+566
| +0.7% | +$14.9K | ﹤0.01% | 1829 |
|
|
2024
Q4 | $2.15M | Sell |
82,661
-357
| -0.4% | -$8.88K | ﹤0.01% | 1847 |
|
|
2024
Q3 | $2.08M | Sell |
83,018
-4,455
| -5% | -$105K | ﹤0.01% | 1892 |
|
|
2024
Q2 | $1.87M | Buy |
87,473
+3,912
| +5% | +$75.9K | ﹤0.01% | 1919 |
|
|
2024
Q1 | $1.55M | Buy |
83,561
+987
| +1% | +$17.3K | ﹤0.01% | 2031 |
|
|
2023
Q4 | $1.34M | Buy |
82,574
+2,207
| +3% | +$28.2K | ﹤0.01% | 2115 |
|
|
2023
Q3 | $1.11M | Buy |
80,367
+116
| +0.1% | +$1.83K | ﹤0.01% | 2146 |
|
|
2023
Q2 | $1.77M | Sell |
80,251
-7,097
| -8% | -$149K | ﹤0.01% | 1978 |
|
|
2023
Q1 | $1.9M | Buy |
87,348
+4,717
| +6% | +$106K | ﹤0.01% | 1832 |
|
|
2022
Q4 | $1.5M | Buy |
82,631
+4,039
| +5% | +$83.4K | ﹤0.01% | 1936 |
|
|
2022
Q3 | $1.79M | Buy |
78,592
+6,480
| +9% | +$139K | ﹤0.01% | 1822 |
|
|
2022
Q2 | $996K | Buy |
72,112
+35,914
| +99% | +$527K | ﹤0.01% | 2147 |
|
|
2022
Q1 | $823K | Sell |
36,198
-15,874
| -30% | -$418K | ﹤0.01% | 2210 |
|
|
2021
Q4 | $1.94M | Sell |
52,072
-7,722
| -13% | -$331K | ﹤0.01% | 1902 |
|
|
2021
Q3 | $2.53M | Buy |
59,794
+36,767
| +160% | +$1.77M | ﹤0.01% | 1763 |
|
|
2021
Q2 | $1.02M | Buy |
23,027
+9,055
| +65% | +$319K | ﹤0.01% | 2237 |
|
|
2021
Q1 | $503K | Buy |
13,972
+335
| +2% | +$13.2K | ﹤0.01% | 2491 |
|
|
2020
Q4 | $544K | Buy |
13,637
+2,525
| +23% | +$86.1K | ﹤0.01% | 2407 |
|
|
2020
Q3 | $322K | Buy |
+11,112
| New | +$240K | ﹤0.01% | 2483 |
|
Other funds holding BLFS
CC
VCM
FAM
